Related references
Note: Only part of the references are listed.Activation of Notch1 signaling by HTLV-1 Tax promotes proliferation of adult T-cell leukemia cells
Wenzhao Cheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma
Abdelbasset Hamrouni et al.
CLINICAL CANCER RESEARCH (2019)
The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads
Yang Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
PD-1 Tumor Suppressor Signaling in T Cell Lymphomas
Tim Wartewig et al.
TRENDS IN IMMUNOLOGY (2019)
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report
Lucy B. Cook et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Hyperprogression as a distinct outcome after immunotherapy
J. Fuentes-Antras et al.
CANCER TREATMENT REVIEWS (2018)
Human T Cell Leukemia Virus Type 1: Persistence and Pathogenesis
Charles R. M. Bangham
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Unlocking the Complexities of Tumor-Associated Regulatory T Cells
Jaime L. Chao et al.
JOURNAL OF IMMUNOLOGY (2018)
Rapid Progression of Adult T-Cell Leukemia-Lymphoma after PD-1 Inhibitor Therapy
Lee Ratner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized mice
Eleonore Peres et al.
PLOS PATHOGENS (2018)
PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma
Keisuke Kataoka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hyperprogressive disease: recognizing a novel pattern to improve patient management
Stephane Champiat et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression
Elena Gianchecchi et al.
FRONTIERS IN IMMUNOLOGY (2018)
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies
Urvi A. Shah et al.
BLOOD (2018)
PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis
Tim Wartewig et al.
NATURE (2017)
CCR8+FOXp3+ Treg cells as master drivers of immune regulation
Yiftah Barsheshet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo
Rie Furuta et al.
PLOS PATHOGENS (2017)
IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways
Leila Sawada et al.
PLOS PATHOGENS (2017)
Comparative Analyses of Signature Genes in Acute Rejection and Operational Tolerance
Jeong-Woo Choi et al.
IMMUNE NETWORK (2017)
PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma
Hiroaki Miyoshi et al.
BLOOD (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
Marco De Simone et al.
IMMUNITY (2016)
Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients
Chien-Hung Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients
Lucy B. M. Cook et al.
RETROVIROLOGY (2016)
PD-1 marks dysfunctional regulatory T cells in malignant gliomas
Daniel E. Lowther et al.
JCI INSIGHT (2016)
Cancer Immunotherapy: A Review
Anna Meiliana et al.
INDONESIAN BIOMEDICAL JOURNAL (2016)
Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
Alan Serrels et al.
CELL (2015)
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
JOURNAL OF CLINICAL INVESTIGATION (2015)
Integrated molecular analysis of adult T cell leukemia/lymphoma
Keisuke Kataoka et al.
NATURE GENETICS (2015)
Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia
Meili Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Functions of the FAK family kinases in T cells: beyond actin cytoskeletal rearrangement
Nicole M. Chapman et al.
IMMUNOLOGIC RESEARCH (2014)
Human T-cell leukemia virus type 1 and Foxp3 expression: viral strategy in vivo
Paola Miyazato et al.
INTERNATIONAL IMMUNOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Polycomb-Mediated Loss of miR-31 Activates NIK-Dependent NF-κB Pathway in Adult T Cell Leukemia and Other Cancers
Makoto Yamagishi et al.
CANCER CELL (2012)
Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function
Ye Su et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
Sylvain Ladoire et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia
Joanna Pancewicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Toll-like receptor signalling on Tregs: to suppress or not to suppress?
Wendy W. C. van Maren et al.
IMMUNOLOGY (2008)
New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses
Dong Zhang et al.
BLOOD (2007)
Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells
SM Chen et al.
INTERNATIONAL IMMUNOLOGY (2006)
IL-8 responsiveness defines a subset of CD8 T cells poised to kill
C Hess et al.
BLOOD (2004)
Share Paper
